MAM
PTLA

MPM Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

MPM Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,220,672
Closed -$52M – 17
2015
Q3 		$52M Hold
1,220,672
– – 8% 3
2015
Q2 		$55.6M Hold
1,220,672
– – 9.3% 2
2015
Q1 		$46.3M Hold
1,220,672
– – 9.88% 2
2014
Q4 		$34.6M Hold
1,220,672
– – 7.68% 4
2014
Q3 		$30.9M Hold
1,220,672
– – 10.1% 3
2014
Q2 		$35.6M Hold
1,220,672
– – 11.98% 3
2014
Q1 		$31.6M Sell
1,220,672
-1,220,672
-50% -$32.6M 13.38% 4
2013
Q4 		$62.9M Hold
2,441,344
– – 20.3% 2
2013
Q3 		$65.3M Hold
2,441,344
– – 18.41% 3
2013
Q2 		$60M Buy
+2,441,344
New +$48.5M 26.55% 2

Other funds holding PTLA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

MPM Asset Management's PTLA Position: Q4 2015 in Review

MPM Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2015, closing a stake of 1,220,672 shares — an estimated $52M sold.

MPM Asset Management first reported a position in PTLA in Q2 2013 and held it in 10 quarters. The position peaked at $65.3M in Q3 2013. 190 funds tracked by Wall St. Rank hold PTLA as of Q4 2015.

  • MPM Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • MPM Asset Management sold 1,220,672 Portola Pharmaceuticals, Inc. shares in Q4 2015, an estimated $52M.
  • MPM Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 10 quarters.
  • MPM Asset Management's Portola Pharmaceuticals, Inc. position peaked at $65.3M in Q3 2013.
  • 190 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2015.

Based on MPM Asset Management's 13F filing for Q4 2015, filed 4 Feb 2016.